Truist Financial Remains a Hold on Pennant Group (PNTG)

In a report released yesterday, Jailendra Singh from Truist Financial maintained a Hold rating on Pennant Group (PNTG – Research Report), with a price target of $22.00. The company’s shares closed yesterday at $20.01.

According to TipRanks, Singh is an analyst with an average return of -14.5% and a 32.39% success rate. Singh covers the Healthcare sector, focusing on stocks such as R1 RCM, IQVIA Holdings, and Evolent Health.

Pennant Group has an analyst consensus of Strong Buy, with a price target consensus of $21.75.

Based on Pennant Group’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $140.19 million and a net profit of $4.38 million. In comparison, last year the company earned a revenue of $118.35 million and had a net profit of $4.83 million

Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PNTG in relation to earlier this year. Last month, John J Gochnour, the COO of PNTG bought 10,700.00 shares for a total of $56,817.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Pennant Group (PNTG) Company Description:

The Pennant Group, Inc. engages in the provision of healthcare services. It operates through the following segments: Home Health and Hospice Services, Senior Living Services, and All Other. The Home Health and Hospice Services segment provides combination of clinical care services such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services. The Senior Living Services segment deals with assisted and independent living and memory care businesses. The All Other segment includes mobile diagnostic and laboratory services. The company was founded on January 24, 2019 and is headquartered in Eagle, ID.